SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001764013-22-000025
Filing Date
2022-01-28
Accepted
2022-01-28 07:14:35
Documents
2
Period of Report
2022-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164337206041811.html 3  
1 FORM 3 wf-form3_164337206041811.xml 3 1751
2 POWER OF ATTORNEY FOR: MARK LEVINE ex-24.htm EX-24 4197
  Complete submission text file 0001764013-22-000025.txt   7400
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address
Levine Mark S. (Reporting) CIK: 0001617236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 22565306

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)